Furosap® Fenugreek Seed Extract
A clinically studied, standardised fenugreek seed extract developed to deliver a consistent profile of furostanolic saponins, including the key marker compound protodioscin.
Introduction
Furosap® is a highly standardised extract of fenugreek seed (Trigonella foenum-graecum L.), developed to deliver a consistent and well-characterised profile of furostanolic saponins, including the key marker compound protodioscin.
Fenugreek has a long history of traditional use, but Furosap® represents a modern, evidence-driven approach — combining botanical heritage with contemporary analytical testing and human clinical research.
Technical Specification
| Specification | Detail |
|---|---|
| Ingredient Name | Furosap® Fenugreek Seed Extract |
| Botanical Name | Trigonella foenum-graecum L. |
| Plant Part Used | Seed |
| Extract Type | Standardised fenugreek seed extract |
| Key Marker Compound | Protodioscin |
| Active Fraction | Furostanolic saponins |
| Test Method | HPLC |
| Typical Study Intake | 500mg daily |
| Typical Use | Male vitality, active lifestyle and performance-focused formulations |
Botanical Identity & Standardisation
Natural plant materials can vary due to growing conditions, harvest timing and processing. To address this variability, Furosap® is standardised to defined active fractions to support batch-to-batch consistency.
The extract is characterised for protodioscin, a furostanolic saponin commonly used as a quality marker, alongside total furostanolic saponins representing the broader active phytochemical profile.
Key Extract Features
- Standardised fenugreek seed extract
- Characterised for protodioscin
- Defined furostanolic saponin profile
- Analysed using HPLC methods
- Used in published human studies
Furostanolic Saponins
Furostanolic saponins are a group of phytochemicals found in fenugreek seed extract. Furosap® is standardised to defined levels of these compounds, including protodioscin as a key analytical marker.
Why Standardisation Matters
Standardisation supports a more consistent and transparent approach compared with loosely characterised botanical powders or extracts.
- Defined active compound profile
- Greater batch-to-batch consistency
- Alignment with clinically studied material
- Improved transparency compared with non-standardised extracts
Composition & Analytical Quality
Furosap® is assessed using laboratory techniques routinely applied to high-quality botanical extracts.
| Parameter | Specification / Typical Result |
|---|---|
| Protodioscin | ≥20% specification; typical results ~23% |
| Total Furostanolic Saponins | ≥45% specification; typical results ~55% |
| Appearance | Light brown to brown powder |
| Solubility | High water solubility |
| Moisture | Low moisture content to support stability |
| Analytical Method | HPLC |
Analytical Characterisation & Ingredient Verification
Furosap® is characterised using analytical techniques commonly applied to high-quality botanical extracts to confirm identity, composition and consistency.
Active Compound Profile
The extract is standardised to defined levels of furostanolic saponins, including the key marker compound protodioscin. These compounds are quantified using HPLC, allowing precise measurement of active constituents.
Consistency & Repeatability
Chromatographic analysis produces a characteristic chemical fingerprint for the extract. Across repeated analyses, key marker compounds appear at consistent positions with stable relative intensity, supporting a repeatable composition from batch to batch.
Identity, Purity & Quality Controls
In addition to active compound verification, the ingredient is assessed against defined quality criteria.
Quality Parameters
- Confirmation of botanical identity
- Assessment of physical characteristics and solubility
- Testing for heavy metals and residual solvents
- Microbiological quality parameters suitable for food supplements
Together, these measures confirm that Furosap® meets its defined specification and is suitable for use in high-quality supplement formulations.
Human Clinical Research
Furosap® has been evaluated in human clinical research, including studies in healthy adult men and resistance-trained men.
Male Vitality & Hormonal Markers
Human clinical studies conducted by academic and clinical research groups in India have evaluated Furosap® in healthy adult men.
- Changes in free and total testosterone markers
- Subjective measures relating to male vitality and wellbeing
- No adverse effects on standard safety markers reported in the study context
Reproductive Health & Performance Context
Additional clinical investigations have examined sperm parameters and resistance-training outcomes.
- Sperm concentration, motility and morphology parameters
- Lean body mass outcomes in resistance-trained men
- Serum testosterone markers compared with placebo in a study setting
Safety & Tolerability
Across published human studies, Furosap® has shown a favourable safety profile when consumed at the studied intake levels.
- Clinical chemistry assessed
- Liver and kidney markers monitored
- Adverse event monitoring included
- No serious adverse effects reported in healthy adult populations during the study periods
Evidence-Led Use Context
Based on its composition and available human research, Furosap® is commonly discussed in relation to male vitality, active lifestyles, body composition and reproductive health research.
Typical Intake Used in Studies
Most human clinical studies investigating Furosap® have used a daily intake of 500mg of the standardised extract, consumed consistently over periods of 8–12 weeks.
Registered Clinical Evaluation
Furosap® has also been evaluated within registered clinical trial frameworks, including listings on ClinicalTrials.gov, reflecting structured investigation under recognised research standards.
Summary
Furosap® is a standardised fenugreek seed extract with defined standardisation to protodioscin and total furostanolic saponins.
The ingredient is supported by analytical characterisation, repeatable testing profiles and multiple human clinical studies exploring male vitality, body composition and reproductive health contexts.
For those seeking a fenugreek extract supported by scientific research and robust quality verification, Furosap® represents a modern, evidence-led option.
Furosap® Fenugreek Seed Extract Capsules
A single-ingredient formulation using Furosap® fenugreek seed extract, standardised to furostanolic saponins including protodioscin.
View ProductReferences
- Maheshwari A. et al. Efficacy of Furosap™, a novel Trigonella foenum-graecum seed extract, in enhancing testosterone level and improving sperm profile in male volunteers. International Journal of Medical Sciences, 2017.
- Guo R. et al. Furosap®, a fenugreek seed extract, improves lean body mass and serum testosterone in a randomised, double-blind, placebo-controlled study. Functional Foods in Health and Disease, 2018.
- Sankhwar S.N. et al. Safety and efficacy of Furosap®, a patented fenugreek seed extract, in healthy men. PubMed-indexed journal, 2021.
- ClinicalTrials.gov. Evaluation of Furosap® in men with testosterone-related symptoms. NCT02748005.
- Wankhede S. et al. Effect of Trigonella foenum-graecum supplementation on strength, body composition and hormonal profile. Journal of the International Society of Sports Nutrition, 2016.
- Hayes L.D., Grace F.M. Herbal ingredients and testosterone: an evidence-based review. Advances in Nutrition, 2022.